Stock DNA
Pharmaceuticals & Biotechnology
USD 23,433 Million (Mid Cap)
30.00
NA
0.00%
0.61
-999,999.00%
2.72
Revenue and Profits:
Net Sales:
3,516 Million
(Quarterly Results - Dec 2025)
Net Profit:
165 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-0.14%
0%
-0.14%
6 Months
-5.09%
0%
-5.09%
1 Year
11.95%
0%
11.95%
2 Years
22.27%
0%
22.27%
3 Years
20.32%
0%
20.32%
4 Years
15.66%
0%
15.66%
5 Years
28.64%
0%
28.64%
Labcorp Holdings, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-0.04%
EBIT Growth (5y)
-12.50%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
27.53%
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
30
Industry P/E
Price to Book Value
2.85
EV to EBIT
23.74
EV to EBITDA
15.39
EV to Capital Employed
2.16
EV to Sales
2.17
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
9.08%
ROE (Latest)
9.42%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 138 Schemes (43.85%)
Foreign Institutions
Held by 350 Foreign Institutions (18.16%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
3,515.80
3,563.50
-1.34%
Operating Profit (PBDIT) excl Other Income
555.00
574.20
-3.34%
Interest
55.00
56.00
-1.79%
Exceptional Items
-114.40
-6.60
-1,633.33%
Consolidate Net Profit
164.90
261.50
-36.94%
Operating Profit Margin (Excl OI)
108.70%
113.10%
-0.44%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is -1.34% vs 1.03% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is -36.94% vs 9.74% in Sep 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
13,951.70
13,008.90
7.25%
Operating Profit (PBDIT) excl Other Income
2,477.30
2,037.90
21.56%
Interest
224.10
208.30
7.59%
Exceptional Items
-142.60
-51.30
-177.97%
Consolidate Net Profit
877.70
747.10
17.48%
Operating Profit Margin (Excl OI)
108.70%
87.50%
2.12%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 7.25% vs 6.97% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 17.48% vs 96.40% in Dec 2024






